Pharmacists in Laplace, LA Accepting Medicare
3 Pharmacists found. Showing 1 - 3
 Mr. Leonard J. Bourgeois, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2021 W. Airline Hyw, Laplace, LA 70068 Phone: 985-652-0174 Fax: 985-652-0637 |
Mr. William Paul Gomla, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 932 Carrollwood Ave., Laplace, LA 70068 Phone: 985-652-1245 Fax: 985-652-7239 |
 Ronalda Joseph, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1500 West Airline Highway, Laplace, LA 70068 Phone: 985-652-6677 |
News Archive
Researchers reveal possible origin of cancer-associated fibroblasts
Researchers at Okayama University describe in Scientific Reports that cancer-associated fibroblasts — cells that play a key role in cancer progression — originate from cancer stem cells. Preventing cancer stem cells from transforming into cancer-associated fibroblast may be a promising approach towards cancer treatment.
Access announces $6.0 million registered direct offering
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, has entered into definitive agreements with existing and new accredited investors to sell, in a registered direct offering, an aggregate of approximately 2.3 million shares of its common stock at a price of $2.55 per share for aggregate gross proceeds of $6.0 million.
Inherited ventricular arrhythmia fairly common among Finnish Leonbergers
A new study in Finland has revealed that inherited malignant ventricular arrhythmia is fairly common among Finnish Leonbergers under three years of age. At its worst, such arrhythmia can result in the dog's sudden death.
NanoScope awarded AGI Grant to re-sensitize photo-degenerated retinal areas with MCO
Millions of individuals affected by Retinitis Pigmentosa (RP) are visually impaired due to photo-degeneration of retina. The visual loss starts with the peripheral region progressing towards the center leading to tunnel vision. Currently, there is no cure to restore vision in these patients. The disease leads not only to physical impairment, but has a significant emotional and psychological impact on quality of life of patients as well as their family members.
Heptares Therapeutics, O2h extend multi-FTE -synthetic chemistry services collaboration
Executives from Heptares Therapeutics (Welwyn Garden City, UK) and O2h (Cambridge, UK) announced today an extension of the agreement under which O2h provides multi-FTE -synthetic chemistry services to support discovery programmes at Heptares.
› Verified 6 days ago